Cargando…
Inhibition of the NLRP3 Inflammasome Activation by Manoalide Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
The activation of NLRP3 inflammasome leads to cell pyroptosis and inflammatory cytokines secretion and gets involved in the development of many diseases, such as neuroinflammation and metabolic syndrome, but the drugs targeting NLRP3 are not clinically available for now. Through screening the small...
Autores principales: | Li, Cong, Lin, Hualong, He, Hongbin, Ma, Ming, Jiang, Wei, Zhou, Rongbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888861/ https://www.ncbi.nlm.nih.gov/pubmed/35252186 http://dx.doi.org/10.3389/fcell.2022.822236 |
Ejemplares similares
-
OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Sánchez-Fernández, Alba, et al.
Publicado: (2019) -
Targeting the NLRP3 Inflammasome via BTK
por: Weber, Alexander N. R.
Publicado: (2021) -
Exosomes Regulate NLRP3 Inflammasome in Diseases
por: Li, Zhangwang, et al.
Publicado: (2022) -
The role of NLRP3 inflammasome in digestive system malignancy
por: Sun, Cen-Cen, et al.
Publicado: (2022) -
Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction
por: Chevriaux, Angélique, et al.
Publicado: (2020)